Lessons learned from statewide contingency management rollouts addressing stimulant use in the Northwestern United States

Prev Med. 2023 Nov:176:107614. doi: 10.1016/j.ypmed.2023.107614. Epub 2023 Jul 13.

Abstract

Increases in stimulant drug use (such as methamphetamine) and related deaths creates an imperative for community settings to adopt evidence-based practices to help people who use stimulants. Contingency management (CM) is a behavioral intervention with decades of research demonstrating efficacy for the treatment of stimulant use disorder, but real-world adoption has been slow, due to well-known implementation barriers, including difficulty funding reinforcers, and stigma. This paper describes the training and technical assistance (TTA) efforts and lessons learned for two state-wide stimulant-focused CM implementation projects in the Northwestern United States (Montana and Washington). A total of 154 providers from 35 community-based service sites received didactic training in CM beginning in 2021. Seventeen of these sites, ten of eleven in Montana (90.9%) and seven of 24 in Washington (29.2%), went on to implement contingency management programs adherent to their state's established CM protocol and received ongoing TTA in the form of implementation coaching calls. These findings illustrate that site-specific barriers such as logistical fit precluded implementation in more than 50% of the trained sites; however, strategies for site-specific tailoring within the required protocol aided implementation, resulting in successful CM program launch in a diverse cross-section of service sites across the states. The lessons learned add to the body of literature describing CM implementation barriers and solutions.

Keywords: Coaching; Contingency management; Implementation; Stimulant use; Substance use disorder; Training.

MeSH terms

  • Behavior Therapy / methods
  • Central Nervous System Stimulants*
  • Humans
  • Methamphetamine*
  • Substance-Related Disorders* / therapy
  • United States
  • Washington

Substances

  • Central Nervous System Stimulants
  • Methamphetamine